Verapamil Hci Injection
Product Images NDC 51662-1442

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Verapamil Hci (NDC 51662-1442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse Reactions (Adverse Reactions)

Adverse Reactions (Adverse Reactions)
This text appears to be describing potential treatments for different adverse reactions in a medical context. The treatments listed include intravenous administration of various medications such as dopamine HCL, calcium chloride, norepinephrine bitartrate, isoproterenol HCL, metaraminol bitartrate, atropine sulfate, procainamide IV, and lidocaine HCL IV. The reactions that these treatments could be used for include symptomatic hypotension, bradycardia, AV block, asystole, and rapid ventricular rate. Additionally, some treatments have specific indications, such as DC-cardioversion for ventricular rate caused by flutter/fibrillation with WPW or LGL syndromes.*
FDA Label Image

Dosage And Administration (Dosage And Administration)

Dosage And Administration (Dosage And Administration)
This text provides dosage information for the administration of a medication through intravenous bolus for adults and children. The initial and repeat doses are given for both age groups, along with the weight range specified for each dose. For older patients, the dose is given over three minutes to minimize drug-related risks. The text also cautions against exceeding the maximum dose for each age group.*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
This is a table of different sizes and NDC numbers for medication vials. There are 5 mg (2 ml) vials with NDC numbers 51754-0203-2 and 51754-0203-4, which come in carton sizes of 5 and 25 respectively. There is also a 10 mg (4 ml) vial with the NDC number 51754-0205-2.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
This is a chemical formula that appears to be incomplete and some of the characters are not readable. It is not possible to retrieve a useful description with this information.*
FDA Label Image

Serialized Labeling (Serialized Vial Labeling)

Serialized Labeling (Serialized Vial Labeling)
This appears to be information related to a medical product. The product is Verapamilh, an injection that comes in a 2mL single-dose vial. It is manufactured and distributed by Beela Pharma Sciences, located in Lenoir, i3. The package should be protected from light, and it is intended for intravenous use only. The product is RX only and the manufacturer's package insert should be referenced.*
FDA Label Image

Vial Labeling (Vial Labeling)

Vial Labeling (Vial Labeling)
This is a prescription drug called Verapamil HCI. It is an injection that is intended for intravenous use only. The drug is manufactured and distributed by Exela Pharma Sciences, located in Lenoir, North Carolina. Each vial contains 2 mL, and any unused portion should be discarded. It is important to protect the drug from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.